Experimental Approaches to the Treatment of Schizophrenia

Events

Experimental Approaches to the Treatment of Schizophrenia

Donald Goff, MD Marvin Stern Professor of Psychiatry, New York University School of Medicine

The Department welcomes Donald Goff, MD to Pittsburgh where he will present a Distinguished Scientist Lecture as part of our regular Friday series.

Dr. Donald GoffDr. Goff is the Marvin Stern Professor of Psychiatry, Director of the Nathan S. Kline Institute, and Associate Director of the Institute for the Study of Decision Making (ISDM) at the New York University (NYU) School of Medicine. Dr. Goff is a translational clinical researcher who studies and treats schizophrenia. He pioneered the development of glutamatergic agents and folate supplementation for individuals with schizophrenia based on models from basic neuroscience and a personalized medicine approach. He is currently working in the areas of early intervention and the treatment of refractory symptoms employing strategies to enhance neuroprotection and neuroplasticity. Dr. Goff was the Director of the Schizophrenia Clinical and Research Program at the Massachusetts General Hospital and Professor of Psychiatry at Harvard Medical School prior to moving to New York in February 2012 to become Vice Chair for Research in Psychiatry at NYU Langone Medical Center and Director of the Nathan Kline Institute for Psychiatric Research. He has published over 200 articles on schizophrenia and related topics. Dr. Goff is the recipient of the Kempf Award for Mentorship in Biological Psychiatry from the American Psychiatric Association; the Wayne Fenton, MD, Award for Exceptional Clinical Care; the Stanley Dean Award for Research in Schizophrenia from the American College of Psychiatrists and the Research Award from the American Psychiatric Association. He is also a member of the American College of Neuropsychopharmacology and an Associate Editor of JAMA.

Date & Time. January 31, 2020, 12:00pm to 1:30pm

Location. UPMC Western Psychiatric Hospital Auditorium

For More Information. Please contact Frances Patrick at patrickfm@upmc.edu.

Learning Objectives. At the conclusion of Dr. Goff's lecture participants will be able to:

  1. Understand the model of excessive hippocampal activation in early schizophrenia and the rationale for levetiracetam as an experimental treatment

  2. Understand the model of impaired memory consolidation as a factor contributing to delusions and the rationale for D-cycloserine as an experimental treatment

  3. Understand the model of hippocampal atrophy as a determinant of clinical course in early psychosis and the rationale for citalopram as an experimental treatment

The entirety of this program will be a lecture by the speaker(s). All individuals able to control the content of this educational activity are required to disclose all relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients. Registration is not required for this event. This event is free and there will be no refunds. The University of Pittsburgh is an affirmative action, equal opportunity institution.
Continuing Education Credit:  The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Pittsburgh School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Each physician should only claim credit commensurate with the extent of their participation in the activity.  Other health care professionals are awarded .15 continuing education units (CEUs), which are equal to 1.5 contact hours.  In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, information about relationships of presenters with commercial interests (if any) will be included in materials which will be distributed at the time of the conference.  WPH is approved by the American Psychological Association to offer continuing education for psychologists. WPH maintains responsibility for this program and its contents.  This program is being offered for 1.5 continuing education credits.
The indicated number of clock hours of continuing education is provided through UPMC Western Psychiatric Hospital’s Office of Educational Resources and Planning, a PA-approved provider of social work continuing education in accordance with all the applicable educational and professional standards of the Pennsylvania State Board of Social Workers, Marriage and Family Therapist.  These clock hours satisfy requirements for LSW/LCSW, LPC and LMFT renewal. For more information, call (412) 204-9085.